Medicine and Dentistry
Crohn's Disease
100%
STEVENS-JOHNSON SYNDROME
100%
Adalimumab
100%
Infliximab
50%
Skin Manifestation
33%
Adverse Event
16%
Immunity
16%
Recurrent Disease
16%
Serositis
16%
Tumor Necrosis Factor
16%
Hydrocortisone
16%
Patient with Crohn's Disease
16%
Side Effect
16%
Desquamation
16%
Exanthem
16%
Arthropathy
16%
Skin Biopsy
16%
Abdominal Wall
16%
Mucositis
16%
Erythema Nodosum
16%
Erythema Multiforme
16%
Monoclonal Antibody
16%
Etanercept
16%
Pharmacology, Toxicology and Pharmaceutical Science
Stevens Johnson Syndrome
100%
Crohn's Disease
100%
Adalimumab
100%
Infliximab
50%
Skin Manifestation
33%
Adverse Event
16%
Recurrent Disease
16%
Tumor Necrosis Factor
16%
Hydrocortisone
16%
Side Effect
16%
Remission
16%
Rash
16%
Arthropathy
16%
Desquamation
16%
Mucosa Inflammation
16%
Inflammation
16%
Monoclonal Antibody
16%
Etanercept
16%
Erythema Multiforme
16%
Erythema Nodosum
16%